Event
Information society
Cleveland Clinic tests gene therapy for cholesterol
2 sourcesPublished · Updated
Researchers at the Cleveland Clinic published results of the first human trial of the experimental drug CTX310. This drug may reduce levels of 'bad' cholesterol in the blood by half and has successfully completed the first phase of trials.
Key facts
- Cleveland Clinic
- Drug CTX310
- First phase of trials
- Cholesterol reduction by half
Cleveland Clinic · CTX310 · New England Journal of Medicine
Sources2
Compare newsrooms
Reports from one newsroom's different channels are grouped together. Different newsrooms can share owners; their count does not establish independent corroboration. How we identify sources and blocs
- Independent
NVEarliest tracked report
Discussion
Comments